# US 2016/0355677 A1 · Toughened polylactic acid polymers and copolymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355677 A1
- Document ID: US20160355677A1
- Status: Published application
- Kind: A1
- Application number: 15/242,993
- Filed: 2016-08-22
- Published: 2016-12-08
- Earliest claimed: 2006-02-07
- Assignees: Tepha, Inc.
- Applicants: Tepha, Inc.
- Inventors: Said Rizk; David P. Martin; Kicherl Ho; Amit Ganatra; Simon F. Williams
- Web page: https://patentgrep.com/patent/US20160355677A1

## CPC

- C08L 67/04: Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence)
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 17/105: {Polyesters not covered by A61L17/12}
- A61L 17/12: Homopolymers or copolymers of glycolic acid or lactic acid
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 29/049: {Mixtures of macromolecular compounds}
- A61L 29/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 31/041: {Mixtures of macromolecular compounds}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/18: Materials at least partially X-ray or laser opaque
- C08G 63/06: derived from hydroxycarboxylic acids
- C08K 3/014: Stabilisers against oxidation, heat, light or ozone
- C08K 5/0016: {Plasticisers}
- C08K 5/005: {Stabilisers against oxidation, heat, light, ozone}
- C08K 5/0083: {Nucleating agents promoting the crystallisation of the polymer matrix}
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)

## Abstract

Toughened compositions of PLA and PLA copolymers are disclosed, which also have low tensile modulus values and greater elongation to break. These toughened compositions are prepared by blending PLA and PLA copolymers with poly-4-hydroxybutyrate, and copolymers thereof. Blending of poly-4-hydroxybutyrate with PLA and its copolymers has been found to impart advantageous properties to the resulting blend. These compositions, and objects formed from these compositions, have improved toughness and lower stiffness than polylactic acid polymers or copolymers alone.

## Claims

### Claim 1

A medical device comprising a toughened polymer composition comprising poly-4-hydroxybutyrate homopolymer or copolymer thereof wherein the composition further comprises at least one polylactic acid homopolymer or copolymer, and the amount of poly-4-hydroxybutyrate homopolymer or copolymer added is sufficient to increase the elongation to break of the composition to greater than the elongation to break of the polylactic acid homopolymer or copolymer.

### Claim 2 (depends on 1)

The medical device of claim 1 wherein the composition has been oriented.

### Claim 3 (depends on 1)

The medical device of claim 1 wherein the elongation to break of the composition is greater than 3%.

### Claim 4 (depends on 3)

The medical device of claim 3 wherein the elongation to break of the composition is between 3% and 281%.

### Claim 5 (depends on 1)

The medical device of claim 1 wherein the Young's modulus of the composition is less than the Young's modulus of the polylactic acid homopolymer or copolymer.

### Claim 6 (depends on 5)

The medical device of claim 5 wherein the Young's modulus of the composition is less than 700 kgf/mm2.

### Claim 7 (depends on 1)

The medical device of claim 1 wherein the ratio of the polylactic acid homopolymer or copolymer to the poly-4-hydroxybutyrate homopolymer is between 9:1 and 1:9 by weight.

### Claim 8 (depends on 1)

The medical device of claim 1 wherein the polylactic acid homopolymer is poly-L-lactic acid.

### Claim 9 (depends on 1)

The medical device of claim 1 wherein the device is a suture, suture fastener, meniscus repair device, rivet, tack, staple, screw, bone plate, bone plating system, biocompatible coating, rotator cuff repair device, surgical mesh, medical textile, repair patch, sling, cardiovascular patch, tissue engineering scaffold, vascular graft, vascular closure device, catheter balloon, anti-adhesion device, drug delivery device, embolization particle, orthopedic pin, adhesion barrier, stent (including coronary stents, peripheral stents, carotid stents, biliary stents, gastroenterology stents, urology stents, and neurology stents), embolization coil, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device (including, but not limited to, atrial septal defect repair devices and PFO closure devices and left atrial appendage (LAA) closure devices), pericardial patch, bulking and filling agent, vein valves, bone marrow scaffold, meniscus regeneration device, ligament graft, tendon graft, ocular cell implant, spinal fusion cage, imaging device, skin substitute, dural substitute, bone graft substitute, bone dowel, would dressing, or a hemostat.

### Claim 10 (depends on 1)

A process for preparing the medical device of claim 1, comprising blending poly-4-hydroxybutyrate homopolymer or copolymer thereof with at least one polylactic acid homopolymer or copolymer, wherein the poly-4-hydroxybutyrate homopolymer or copolymer thereof and at least one polylactic acid homopolymer are mixed in the molten state at a temperature between 110° C. and 230° C., and extruded.

### Claim 11 (depends on 8)

The process of claim 8 further comprising extruding the toughened composition, wherein the composition is dried to a water content of less than 0.01% (w/w) prior to extrusion, and wherein the composition is extruded at a temperature between 140° C. and 250° C.

### Claim 12 (depends on 9)

The process of claim 9 wherein the extrudate is oriented by drawing it with stretch ratios of 1X to 11X.
